Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis
AbstractBackground Arteriovenous fistula (AVF) dysfunction is a common complication in patients undergoing maintenance hemodialysis (MHD). Elevated serum levels of fibroblast growth factor 21 (FGF21) are associated with atherosclerosis and cardiovascular mortality. However, its association with vasc...
Main Authors: | Xinhui Hu, Hong Ding, Qing Wei, Ruoxin Chen, Weiting Zhao, Liqiong Jiang, Jing Wang, Haifei Liu, Jingyuan Cao, Hong Liu, Bin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2302407 |
Similar Items
-
Analysis of patency rates and factors associated with arteriovenous fistula in maintenance hemodialysis patients followed for 10 years
by: Ping Liu, et al.
Published: (2023-12-01) -
Factors associated with the patency loss of arteriovenous fistula for hemodialysis
by: Zlatko Maksimović, et al.
Published: (2018-07-01) -
Factors affecting the long term patency of arteriovenous access for hemodialysis: A single center experience
by: Ashwini Naveen Gangadharan, et al.
Published: (2021-01-01) -
Hyperphosphatemia is associated with patency loss of arteriovenous fistula after 1 year of hemodialysis
by: Ju-Young Moon, et al.
Published: (2015-03-01) -
EFFECT OF HEPARIN ON THE PATENCY OF ARTERIOVENOUS FISTULA
by: H Ravari, et al.
Published: (2008-11-01)